Lupin Logo
Lupin Logo
Mumbai

Cart

Your cart is empty

Add tests or packages to get started

HomePackageLupi Glp 1 Care Package

Lupi GLP-1 Care Package (Pre-Therapy Screening)

About Lupi GLP-1 Care Package (Pre-Therapy Screening)

SampleCollectionReportGenderTurnaround
Blood + UrineCentre VisitDigital ReportMale/Female24–48 Hours

Note: Home collection is not available for this package. Patients must visit a Lupin Diagnostics centre. Use the centre locator on the website to find your nearest location.

What is GLP-1 Therapy?

GLP-1 stands for Glucagon-Like Peptide-1, a hormone your body produces naturally to help regulate blood sugar and appetite. GLP-1 receptor agonists are a class of medicines that mimic this hormone. Common examples include semaglutide (sold as Ozempic and Wegovy), tirzepatide (Mounjaro), and oral semaglutide (Rybelsus). Doctors prescribe these medicines to manage type-2 diabetes and, in some cases, for weight management in adults with obesity or weight-related health conditions.

Because GLP-1 medicines affect multiple organ systems, including the pancreas, liver, kidneys, and thyroid gland, doctors often recommend a baseline health assessment before starting treatment. This helps confirm that GLP-1 therapy is appropriate for you and provides a reference point for tracking your health over time.

What is the Lupi GLP-1 Care Package?

The Lupi GLP-1 Care Package is a pre-therapy screening panel offered by Lupin Diagnostics. It includes 18 tests covering every organ system that GLP-1 therapy can affect: blood sugar control, insulin resistance, pancreatic enzyme levels, liver and kidney function, thyroid hormones, cholesterol and heart health, inflammation markers, and nutritional status.

The package is designed to give you and your doctor a comprehensive health baseline before you begin GLP-1 treatment. Results are delivered as a digital report within 24–48 hours of sample collection from NABL- and CAP-accredited Lupin Diagnostics laboratories.

This package is available at Lupin Diagnostics centres. Home collection is not available for this particular panel.

What Tests Are Included in the Lupi GLP-1 Care Package?

The package covers 18 tests grouped into eight health profiles. The table below lists each test, its health profile, parameters included, and its relevance to GLP-1 therapy screening.

Test NameHealth ProfileParameters TestedWhy It Is Included
Complete Blood Count (CBC)Anaemia and General HealthRBC, WBC, Platelets, Haemoglobin, Haematocrit, MCV, MCH, MCHCScreens for anaemia and assesses general blood health before therapy. A pre-therapy baseline is useful as GLP-1 medicines can reduce appetite over time.
ESR (Erythrocyte Sedimentation Rate)InflammationErythrocyte Sedimentation RateMeasures how quickly red blood cells settle. Helps distinguish pre-existing inflammation from side effects that may develop after therapy starts.
Thyroid Profile Free (TSH, Free T3, Free T4)Thyroid HealthTSH, Free T3, Free T4Assesses thyroid function. A history of certain thyroid cancers is a recognised contraindication to some GLP-1 medicines, making this an important safety check.
Lipid ProfileHeart and Metabolic HealthTotal Cholesterol, HDL, LDL, VLDL, Non-HDL, TriglyceridesEstablishes a cardiovascular baseline. GLP-1 therapy can improve lipid levels over time, so a pre-treatment reading allows your doctor to measure that benefit.
hsCRP (High-Sensitivity C-Reactive Protein)Inflammation and Cardiac Riskhs-CRPDetects low-level chronic inflammation linked to metabolic disease and cardiovascular risk. It is more sensitive than the standard CRP test.
HbA1c (Glycated Haemoglobin)Blood Sugar ControlHbA1c %Reflects average blood sugar over the past two to three months. Confirms your starting blood sugar status and measures how well GLP-1 therapy is working over time.
Iron Studies — BasicAnaemia and NutritionSerum Iron, TIBC, FerritinAssesses iron stores and transport. GLP-1 medicines can reduce appetite and lower dietary iron intake, so identifying a deficiency before treatment is important.
LipasePancreatic SafetyLipaseElevated lipase can indicate pancreatic inflammation (pancreatitis), which is a contraindication to some GLP-1 medicines. An important pre-therapy safety check.
Amylase, SerumPancreatic SafetyAmylaseTested alongside lipase for a complete picture of pancreatic health. Together they screen for pre-existing pancreatic inflammation.
Kidney / Renal Function Tests Gold (KFT Gold)Kidney FunctioneGFR, Creatinine, BUN, Uric Acid, Blood Urea, Albumin-to-Creatinine Ratio (ACR)A detailed renal baseline. GLP-1 medicines can affect kidney fluid handling, and some kidney conditions may require dose adjustments.
Complete Urine ExaminationKidney and Metabolic HealthProtein, Glucose, pH, Specific Gravity, Ketones, Bilirubin, CellsChecks for urinary protein, glucose, and other markers to complement the blood-based kidney tests in this panel.
Liver Function Test Gold (LFT Gold)Liver FunctionSGOT, SGPT, ALP, Bilirubin (Total, Direct, Indirect), Total Protein, Albumin, GlobulinEstablishes a detailed liver baseline. GLP-1 medicines are processed by the liver, and pre-existing liver disease can affect how the body handles the medication.
GGT (Gamma Glutamyl Transferase)Liver FunctionGGTOne of the most sensitive liver enzymes. Can detect early fatty liver and alcohol-related changes that a standard liver test may miss. Included alongside LFT Gold for a more complete liver picture.
Vitamin B12 (Cyanocobalamin)Nutritional HealthVitamin B12Essential for nerve function and red blood cell production. GLP-1 therapy can reduce food intake, raising the risk of B12 deficiency over time.
Vitamin D, 25-OHNutritional Health25-Hydroxyvitamin DDeficiency is common in people with obesity or metabolic disease and may worsen insulin resistance. Identifying it before therapy allows early correction.
HOMA-IR (Insulin Resistance Index)Insulin ResistanceFasting Glucose, Fasting Insulin, HOMA-IR ScoreDirectly measures insulin resistance, the core metabolic problem GLP-1 therapy addresses. Provides a precise pre-treatment quantification.
C-PeptidePancreatic Beta Cell FunctionC-PeptideMeasures how much insulin the pancreas is still producing. Helps distinguish type 1 from type 2 diabetes and predict likely response to GLP-1 therapy.
Lipoprotein (a) [Lp(a)]Advanced Cardiac RiskLp(a)A genetically determined cardiovascular risk marker not captured by standard cholesterol tests and not significantly changed by GLP-1 therapy. Important to document at baseline.

Why Screening Before GLP-1 Therapy Is Recommended

Doctors generally recommend a baseline health assessment before starting GLP-1 therapy. This is not a mandatory requirement in every case, but it is considered good clinical practice. Here are the main reasons why pre-therapy screening can be beneficial:

  1. It Helps Identify Safety Concerns Early
    Some health conditions may make GLP-1 therapy unsuitable or require closer monitoring. For example, a personal or family history of certain thyroid cancers or active pancreatic inflammation are conditions a doctor needs to be aware of before prescribing GLP-1 therapy. Pre-therapy screening can bring these to light before treatment begins.
  2. It Establishes a Baseline for Monitoring
    GLP-1 therapy affects blood sugar, cholesterol, kidney function, and liver health. Having a record of these values before treatment allows your doctor to track changes over time, making it easier to identify genuine improvements or early warning signs.
  3. It Supports Personalised Treatment Planning
    Everyone's metabolism, organ function, and nutritional status are different. A comprehensive baseline gives your doctor the information needed to select the most appropriate starting dose and to adjust treatment as your health changes.
  4. It Helps Identify Nutritional Deficiencies Early
    GLP-1 medicines often reduce appetite, which can lead to lower intake of nutrients such as iron, Vitamin B12, and Vitamin D. Knowing your nutritional status before therapy starts makes it easier to correct deficiencies and to interpret any symptoms that arise later.
  5. It Creates a Reference for Side Effect Assessment
    If symptoms such as fatigue, nausea, or changes in kidney or liver markers occur during therapy, baseline test results help your doctor determine whether they are related to the treatment or were present beforehand.

Important: The information above is for general awareness only. Whether pre-therapy screening is appropriate for you will depend on your individual health history and your doctor's clinical judgement. Always consult your doctor before booking any diagnostic test.

Who Is the Lupi GLP-1 Care Package Suitable For?

The Lupi GLP-1 Care Package is intended for adults who may benefit from a comprehensive pre-therapy health assessment. It may be relevant for the following groups:

  • Adults who are planning to start GLP-1 therapy for the first time (Ozempic, Wegovy, Mounjaro, or Rybelsus) and would like a comprehensive baseline assessment before beginning.
  • People with type-2 diabetes, pre-diabetes, or suspected insulin resistance who are being considered for GLP-1 treatment as part of their diabetes management plan.
  • Adults with a body mass index (BMI) of 27 or above who are exploring medical weight management options and whose doctor has recommended pre-therapy screening.
  • Individuals with a personal or family history of pancreatitis, thyroid disease, liver disease, or chronic kidney disease, where a comprehensive baseline is especially important before starting any new medication.
  • Patients whose doctor has specifically requested a detailed pre-GLP-1 screening panel before writing a prescription.
  • Those who want the most detailed metabolic baseline before committing to long-term GLP-1 therapy.

Note: This list is for general guidance only. Whether this package is right for you should be determined in consultation with your doctor. Please do not self-diagnose or use these tests as a substitute for professional medical advice.

Key Features of This Package

The Lupi GLP-1 Care Package covers a broader range of tests than most standard GLP-1 pre-therapy panels. Here is what distinguishes it:

  • Covers all organ systems affected by GLP-1 therapy, including the pancreas, liver, kidneys, and thyroid, in a single visit.
  • Identifies safety concerns and helps rule out contraindications before therapy begins.
  • Establishes a baseline to monitor treatment effects and detect side effects over time.
  • Includes C-Peptide to help determine diabetes type and predict therapy response, absent in most standard pre-therapy panels.
  • Includes Lipoprotein (a) [Lp(a)], an independent cardiac risk marker not captured by routine cholesterol tests.
  • Uses hsCRP for a more sensitive measure of cardiovascular and metabolic inflammation than standard CRP.
  • Supports personalised treatment planning based on your individual health profile.
  • Provides actionable insights you can share with your doctor or nutritionist.
  • Results delivered as a digital report from NABL- and CAP-accredited labs within 24–48 hours.

Booking Your Lupi GLP-1 Care Package

This package is available exclusively at Lupin Diagnostics centres. Home sample collection is not available. Please follow the steps below to book your test:

  1. Find Your Centre: Visit the Lupin Diagnostics website and use the centre locator to find your nearest branch. Make a note of the centre's contact number and opening hours.
  2. Book Your Appointment: Call the centre directly or book online through the Lupin Diagnostics website. You can also call 7030 300 400 for assistance. Early morning slots are recommended as fasting is required.
  3. Attend Your Appointment: Arrive at the centre on the date and time you have booked. A trained phlebotomist will collect your blood and urine samples. Sample collection takes approximately 10–15 minutes.
  4. Receive Your Report: Your digital report will be delivered to your registered email address and through the Lupin Diagnostics app within 24–48 hours of sample collection.

Note: Please book your appointment for a morning time slot when possible. Most tests in this panel require fasting, and morning collection makes the fasting period easier to manage.

How to Prepare for the Lupi GLP-1 Care Package

Follow these preparation steps to ensure your test results are as accurate as possible:

  • Fast for 10–12 hours before your appointment. Water is permitted.
  • Inform the centre about all medications and supplements you are currently taking.
  • Stay well hydrated — drink water normally even during the fasting period.
  • Book a morning appointment where possible.
  • Wear comfortable, loose-sleeved clothing.
  • Bring a valid photo ID and any referral documents from your doctor.

What You Can Do Before the Test:

  • Drink plain water freely
  • Take prescribed medication as normal (unless your doctor advises otherwise)
  • Attend at your booked time
  • Inform staff of any medical conditions

What to Avoid:

  • Eating or drinking anything other than water for 10–12 hours before the test
  • Taking new supplements or over-the-counter medicines without telling your doctor first
  • Arriving without having fasted; this will affect the accuracy of several test results
  • Strenuous exercise immediately before the test, as this can affect some readings

Report Turnaround: Most results are available within 24–48 hours of sample collection. Some specialist tests (such as Lipoprotein (a) and C-Peptide) may occasionally take slightly longer. Please confirm with your centre if you need results urgently.

Start Your GLP-1 Journey with a Clear Health Baseline

The Lupi GLP-1 Care Package brings together 18 carefully selected tests covering every organ system relevant to safe and effective GLP-1 therapy. From blood sugar and insulin resistance to pancreatic safety, liver health, kidney function, thyroid hormones, and advanced cardiac risk markers including C-Peptide and Lipoprotein (a), it is the most comprehensive pre-therapy panel in the Lupin Diagnostics metabolic range.

Having a detailed health baseline before you begin treatment gives you and your doctor the clearest possible picture of where your health stands, and a reliable reference point to track your progress once therapy starts.

The Lupi GLP-1 Care Package is available at Lupin Diagnostics NABL- and CAP-accredited centres at ₹4,500. Results are delivered as a digital report within 24–48 hours.

To book, visit your nearest Lupin Diagnostics centre or call 7030 300 400.

Frequently Asked Questions

The Lupi GLP-1 Care Package is an 18-test pre-therapy screening panel from Lupin Diagnostics. It covers blood sugar control, insulin resistance, pancreatic safety, liver and kidney health, thyroid hormones, cholesterol, anaemia, nutritional status, and advanced metabolic markers, giving your doctor a complete health baseline before GLP-1 therapy begins.

No, the Lupi GLP-1 Care Package is currently available only at Lupin Diagnostics centres. Home collection is not available for this panel. Please use the centre locator on the Lupin Diagnostics website to find your nearest centre, or call 7030 300 400 for assistance.

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a calculated score based on fasting glucose and insulin levels. A higher score indicates insulin resistance, one of the core metabolic problems GLP-1 therapy addresses. It gives your doctor a precise baseline measure beyond blood sugar levels alone.

C-Peptide measures how much insulin your pancreas is still producing. It helps distinguish type 1 from type 2 diabetes and indicates whether GLP-1 therapy alone is appropriate or whether additional treatment may be needed. Results should always be interpreted by a doctor in the context of your full health history.

Lp(a) is a cholesterol-carrying particle whose levels are largely determined by genetics and are not changed by GLP-1 therapy or diet. It is an independent cardiovascular risk marker that standard lipid tests do not capture, making it important to document at baseline. Always discuss results with your doctor.

A prescription is not required to book this package. However, results, particularly HOMA-IR, C-Peptide, and Lp(a), are most meaningful when reviewed by a doctor who knows your full health history. Do not self-diagnose or alter any medication based on your results without medical guidance.

Most results from the Lupi GLP-1 Care Package are available within 24–48 hours of sample collection. Your digital report will be delivered to your registered email address. Some specialist tests, particularly Lipoprotein (a) and C-Peptide, may occasionally take slightly longer to process. If you need your results by a specific date, please inform the centre staff at the time of booking.

Abnormal results do not mean GLP-1 therapy is unsuitable for you. Share your report with your doctor as soon as it is available. They will review each finding, advise on any follow-up tests, and determine next steps. Do not adjust any medication without medical advice.

The Lupi GLP-1 Care Package price starts at ₹4,500. To book this package, go to lupindiagnostics.com/, visit your nearest Lupin Diagnostics centre, or call 7030 300 400.

A standard full-body check-up provides a general health overview. This package specifically targets every organ system that GLP-1 therapy affects, including pancreatic safety markers, insulin resistance (HOMA-IR), and advanced cardiac risk (Lp(a)), which are not part of most routine health panels.

Lupi GLP-1 Care Package (Pre-Therapy Screening)

Price
4,500.00
Promo Fallback